Peder Walberg

Peder's background includes being the founder and CEO of Rare Thyroid Therapeutics and Medical Need Europe and co-founder of Wilson Therapeutics. Peder has also served as EVP Business Development and Strategy at Swedish Orphan and Sobi and Nordic Head of New Products and BD&L at Novartis. He has previously been a director of the board of Wilson Therapeutics and OxThera and has a background as a management consultant with the Boston Consulting Group.